Which condition is NOT an indication for administering RhIg (Rhogam)?

RhIg (Rho(D) immune globulin) is administered to prevent Rh sensitization in Rh-negative mothers who may be exposed to Rh-positive blood. Sensitization typically occurs during events where fetal blood cells could enter maternal circulation, posing a risk for subsequent pregnancies.

Elective abortion, bleeding previa, and ectopic pregnancy are all scenarios in which there is a potential for fetal blood cells to enter the maternal bloodstream, making RhIg administration an important consideration to protect future pregnancies from Rh incompatibility.

In contrast, gestational hypertension does not inherently create a risk for maternal-fetal blood mixing in the same way that the other conditions do. While the health of the mother and fetus is still a concern in cases of gestational hypertension, there is no direct indication for administering RhIg in this context. Thus, this condition is not an indication for RhIg administration.